You have 9 free searches left this month | for more free features.

glimepiride

Showing 26 - 50 of 128

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes Trial (Omarigliptin, Placebo to Omarigliptin, Glimepiride)

Completed
  • Type 2 Diabetes Mellitus
  • (no location specified)
Aug 8, 2018

Diabetes, Type II Trial in Hanover (Empagliflozin, Glimepiride, Empagliflozin )

Terminated
  • Diabetes Mellitus, Type II
  • Hanover, Lower Saxony, Germany
    Hannover Medical School, University Eye Hospital and CRC Core Fa
Sep 26, 2018

Type 2 Diabetes Trial (Omarigliptin, Matching to Omarigliptin, Glimepiride)

Completed
  • Type 2 Diabetes Mellitus
  • (no location specified)
Aug 9, 2018

Type 2 Diabetes Trial in Nanjing (Saxagliptin, Glimepiride)

Completed
  • Type 2 Diabetes
  • Nanjing, Jiangsu, China
    at Division of Endocrinology, the Affiliated Drum Tower Hospital
Jul 19, 2018

Type 2 Diabetes Trial (Omarigliptin, Matching to omarigliptin, Glimepiride)

Completed
  • Type 2 Diabetes Mellitus
  • (no location specified)
Aug 9, 2018

Type 2 Diabetes Trial (Ertugliflozin 5 mg, Ertugliflozin 15 mg, Placebo matching ertugliflozin)

Completed
  • Type 2 Diabetes Mellitus
  • Ertugliflozin 5 mg
  • +4 more
  • (no location specified)
Nov 13, 2018

Type 2 Diabetes Trial (drug, other, biological)

Completed
  • Type 2 Diabetes Mellitus
  • Ertugliflozin 5 mg
  • +6 more
  • (no location specified)
Aug 9, 2018

Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )

Completed
  • Diabetes Mellitus, Type 2
  • Athens, Alabama
  • +612 more
Dec 19, 2019

Type 2 Diabetes Trial (Sitagliptin phosphate, Comparator: Placebo, Acarbose)

Completed
  • Type 2 Diabetes Mellitus
  • Sitagliptin phosphate
  • +3 more
  • (no location specified)
Jul 19, 2018

Type 2 Diabetes Trial (Ertugliflozin 5 mg, Ertugliflozin 15 mg, Placebo for ertugliflozin 5 mg)

Completed
  • Type 2 Diabetes Mellitus
  • Ertugliflozin 5 mg
  • +7 more
  • (no location specified)
Aug 15, 2018

Type 2 Diabetes, Inadequate Glycaemic Control Trial in Worldwide (Dapagliflozin, Saxagliptin, Glimepiride)

Completed
  • Type 2 Diabetes Mellitus
  • Inadequate Glycaemic Control
  • Hodonin, Czechia
  • +172 more
Mar 22, 2019

Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Hueytown, Alabama
  • +102 more
Sep 3, 2018

Diabetes, Type 2 Trial in Worldwide (Glimepiride, Metformin, Pioglitazone)

Terminated
  • Diabetes Mellitus, Type 2
  • Glimepiride
  • +9 more
  • Miami, Florida
  • +33 more
Sep 25, 2019

Type 2 Diabetes, Hypoglycemia Trial in Colombia (vildagliptin and metformin (combination), glimepiride, Metformin)

Completed
  • Type 2 Diabetes
  • Hypoglycemia
  • vildagliptin and metformin (combination)
  • +2 more
  • MedellĂ­n, Antioquia, Colombia
  • +7 more
Apr 13, 2017

Type 2 Diabetes Trial in Chiyoda-Ku (Sitagliptin, Glimepiride)

Completed
  • Type 2 Diabetes
  • Chiyoda-Ku, Tokyo, Japan
    Japan Association for Diabetes Education and Care
Mar 3, 2017

Type 2 Diabetes Trial in Korea, Republic of (Nateglinide, Glimepiride)

Completed
  • Type 2 Diabetes Mellitus
  • Ilsan, Kyounggi, Korea, Republic of
  • +6 more
May 15, 2017

Type 2 Diabetes Trial (Ertugliflozin 5 mg, Ertugliflozin 10 mg, Placebo to Ertugliflozin)

Completed
  • Type 2 Diabetes Mellitus
  • Ertugliflozin 5 mg
  • +5 more
  • (no location specified)
Sep 1, 2017

Diabetes, Diabetes, Type 2 Trial in Adelaide, Neuss (liraglutide, , glimepiride)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Adelaide, South Australia, Australia
  • +1 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in Rochester (liraglutide, , glimepiride)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Rochester, Minnesota
    Novo Nordisk Investigational Site
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (rosiglitazone, inhaled human insulin, glimepiride)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • St Leonards, New South Wales, Australia
  • +25 more
Feb 28, 2017

Diabetes, Type 2 Trial in Vicente Lopez (Dapagliflozin, Glimepiride, Dapagliflozin + Glimepiride)

Completed
  • Diabetes Mellitus, Type 2
  • Vicente Lopez, Buenos Aires, Argentina
    Local Institution
Oct 14, 2016

Type II Diabetes Trial in Mainz (Vildagliptin, Glimepiride)

Completed
  • Type II Diabetes Mellitus
  • Mainz, Germany
    Novartis Investigative Site
Nov 16, 2016

Type 2 Diabetes Trial in Austin (Dapagliflozin, Glimepiride, Sitagliptin)

Completed
  • Type 2 Diabetes Mellitus
  • Austin, Texas
    Ppd Development
Oct 14, 2016

Diabetes, Diabetes, Type 2 Trial in China, Japan (biphasic insulin aspart 30, metformin, glimepiride)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart 30
  • +3 more
  • Beijing, Beijing, China
  • +33 more
Jan 10, 2017